Figure 3 - full size

 

Figure 3.
FIG. 3. Lovastatin and LFA878 inhibit the binding of mAb R7.1 to LFA-1 in human blood in vitro. The binding of fluorescein isothiocyanate-labeled mAb R7.1 to leukocytes in human whole blood was quantified in the presence of lovastatin (Lov.) (100 µM) (A) or LFA878 (30 µM) (B) by flow cytometry as described under "Experimental Procedures." Red profiles indicate the binding of mAb R7.1 to lymphocytes, granulocytes, or monocytes in the presence of compound; black profiles such binding in the presence of the solvent control. A representative experiment is shown.

The above figure is reprinted by permission from the ASBMB: J Biol Chem (2004, 279, 46764-46771) copyright 2004.